pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4749 |
Genomic Coordinates | chr19: 49854591 - 49854651 |
Description | Homo sapiens miR-4749 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4749-3p | ||||||||||||||||||||||||||||||
Sequence | 42| CGCCCCUCCUGCCCCCACAG |61 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FAM53C | ||||||||||||||||||||
Synonyms | C5orf6 | ||||||||||||||||||||
Description | family with sequence similarity 53 member C | ||||||||||||||||||||
Transcript | NM_001135647 | ||||||||||||||||||||
Other Transcripts | NM_016605 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FAM53C | |||||||||||||||||||||
3'UTR of FAM53C (miRNA target sites are highlighted) |
>FAM53C|NM_001135647|3'UTR 1 AACTGAGAGGCTACTTCCTGGGGCCACACAGACTGACTCTCTCATGGCTACTAACAAGTGTCGAGTCCCCAAGGCTGGGG 81 GCCGAGCCTGGGAATGGGGGTGAGTGGAGGGCTCCGACTCAGGGCAGCTGGAAATCTTCTCGCTCCAGCAAGCTCGACCA 161 TGCCAAGAGACTGGCCGGGACAAGATAAACGGAGCTGGTGGCGGGAGGGACAGCCCCAGAGCAGACCCTTCCTATGGCGG 241 CCCTGAGTGTGAGTATCCCTGCCACCAAGAGAGCAATGGGCAGGGAAGGAAGGGGTCTGCCGACCCCAGCTCGGGGAATT 321 TCACTAGCCCCTTTGCTTCAAAGGGCACTTGTGTCTTAGAATTTGGCCAGGGTGGGGGGTTGAGTCAGCCTCCTCAGAGA 401 AACTGCGTGAGAGTGTGTGCGTGCATGGGAGTGTACTTGTGGAAAGGTGTGTTTGCGTAGCCTTAGGGAAGGAAGGCAAT 481 TGCTCCTTAACAGCAGAGTATCATGATACCCCCAGGATCTTGAGTTTTTTACAGGATGTTGGGTTTGCTCAAGGAGTCAA 561 GAGGAGGGCACCAAGTTTTCCTTTTTTCTAAATAGCTCTGGAACCAGGCTTGTAATCCATAGCATCACCGACTCTGCAAA 641 GGATTTCATTTTGGGGTACAGCAGGGTGTTTTAAGTGCTGTGACTTCAGCTAATGATCTTTTCTTCAGCCCCACCCCCTC 721 CCCACTAGCTCGATCTAGTATATTGGGGAATGCAGGTGGGGGGTGTCACCATATTTTTTCTGAGCTGGCCTTTTTTTCTC 801 ATCAGATTGTCCAGGCTATATTCCACCTGCCTCTTTTGCCCTCTTGAGTAGAGTTGCACACAGCACATGGGCAACTGAAG 881 CAGGGTTGAGGGGCTCTCTCTCTCTCTCCTCTGCTGATGGGACCCTTTTCCCCTCACCCTCTGCCCTTCTAAGTCATAGA 961 CTAGGTAGGAAGGCCCTATATTGGTCCCCAGCATCTACTGAGGCAGACCTGCAACAGAAGTGGCATTCAGTCCCCAGCAG 1041 ACATGGGTGAGCTCACCCCAGCACTGCTGTTGGGAAGGTGACTGCAGGAAACCAATTCTTACAAGATCCAGGCCCAGCCT 1121 TTTTGACCTGCTTGAGAGGGAAGAAGGGGTGTTTAGCATTTAATAGTTTGCTTGTCTTCCACTCCTGCCAGGAAGTGTTT 1201 ATTTGCCTCTAATTGGGCCTGAGAGACCATAGGGAGGTTGGGGCTCACTGAGGGATTGGCTGAGGATGTATAAAGCAAAG 1281 GCTGTGAGAAGCAGTTGGGAGTTTGGTTGTCATTGGATTGAATTTACTTTTTTGTTTCTCACCCGCAACTTGAGCCAGGA 1361 CAGCTGGTCCAAGTGGCCACAGTGATGGGTTTAAGTACCTTGGTAGGGCTGGCACCAGTGGAAACACATACTGAAGCTGC 1441 CACCACAATAGCTTGTGAGGTTTTATCCAGCTGTGGTTAGACCCTGCATGACCAAATTTGACCTGCCCTTGTTTATGGCA 1521 AGAAGGGCATTTTTCTCTTCAATTTCCAGGGTTTCCTAGGACCCAGTTCCTCATGTAAGGGAGGAAGACCAAGGTCTTTG 1601 TGTTTTCTTCCTCATGGAATTGAACCTGACATTTTCTGGATCTCCTGCATGTCAGGAGCATCAGTGAGGCTTCAGCCTCC 1681 TCGTCTCCACTCCAGAGAGGAGGTGGCTATGTCTTCTTAAGCCTCTGGCCCTCAGAGGCTCCTCCCTATCTCCTGGCTAG 1761 TTACCACTAGGCTACCAGGTCTCTAGGGGCCTGAGAGAGGCCCTCTAGAGAATCCAGGGAAACTGTGAGCCCAGGAGTTG 1841 CCCATCTATGGTTTCATTCCTCCCCTGGCTCTTCTCCCTCTTCAGGCCATAATTTCCCTGGTGCCAATTTCTTTTCCTCC 1921 TGGGGCATCCTCATCCCAGGGCTCTCTGCTGTAGATTGGCTGTGCCAGCTTCCAACAGGTTACTGGCAATGCCAGTGAGT 2001 TTCTGTAGGCCCTAAGCTGAAGAAGTGAGGCAGTGATTCTGCCTCCATCCTGGTTTCCCCAAAGCCCCAGGGCACCATCC 2081 TTAGGGGAGAAGGTCTACAGTTATCATTATTTTAATTCCATTACTTTCAGTCTGGAAAACTAAGCTAGTCAGAACTGTCA 2161 TCTTGCTTCCCAATCTAAGAACCTGTGGCCCTGGAACACTTTTCAAGAATTGGTTCATTTTGCTTTACACAGTAGATCTG 2241 TTCCAACAGTTCTGTGTAAACCAAATGCTATTTTTCAATGCATTTGGACTGCTGACCATTTAAAAGCAGCCTATGATTGC 2321 TTCTTTTTGTAAAGCAAGCAACCTCCCTCCACTTTAGCTGTTTTGACTATTTGAATTTTCACATATTGGGCTTACCCAGA 2401 GTGGAGCACACCTCCAGGGCATGTGGCTGACACTGGGTCAATGTCTGCATCTGTGCTGTGTGTGTAGTGTGGTTGGCCAG 2481 TAGGTGAGTATCCCTGTGTGTGTGAGTGAAGCCACTCCCCAGGCTGGTGCTCTCCTCCTGTGCCCAGTGACTGCCCAGTG 2561 GCAGCTCAGCTGCCCTTCACTCCCACCTGCTGCCAAAGTCCCTGTGCTAATGGGATTACAAATACAAAAAGTGGAAAAAA 2641 ATTTTCGTAAACTTTGTTTTATATTAAAAGAAAAATCCATAAGTCTGTGTGTGTTAAACATGAGGTTCTGCCTCTGTGGC 2721 TGTGTTTGAAAAAATAAAGTTTTATTAGAATAATCCATTTTCCCAAGCAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HeLa | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Chi_124A_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell miR-124 + A
... - Chi SW; Zang JB; Mele A; Darnell RB, 2009, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Chi SW; Zang JB; Mele A; Darnell RB - Nature, 2009
MicroRNAs (miRNAs) have critical roles in the regulation of gene expression; however, as miRNA activity requires base pairing with only 6-8 nucleotides of messenger RNA, predicting target mRNAs is a major challenge. Recently, high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) has identified functional protein-RNA interaction sites. Here we use HITS-CLIP to covalently crosslink native argonaute (Ago, also called Eif2c) protein-RNA complexes in mouse brain. This produced two simultaneous data sets-Ago-miRNA and Ago-mRNA binding sites-that were combined with bioinformatic analysis to identify interaction sites between miRNA and target mRNA. We validated genome-wide interaction maps for miR-124, and generated additional maps for the 20 most abundant miRNAs present in P13 mouse brain. Ago HITS-CLIP provides a general platform for exploring the specificity and range of miRNA action in vivo, and identifies precise sequences for targeting clinically relevant miRNA-mRNA interactions.
LinkOut: [PMID: 19536157]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset Chi_124A_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell miR-124 + A |
Location of target site | ENST00000513056.1 | 3UTR | AGGGGCUCUCUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000513056.1 | 3UTR | AGCAGGGUUGAGGGGCUCUCUCUCUCUCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000513056.1 | 3UTR | UGAGGGGCUCUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
63 hsa-miR-4749-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT082256 | MED29 | mediator complex subunit 29 | 2 | 4 | ||||||||
MIRT112161 | OTUD3 | OTU deubiquitinase 3 | 2 | 2 | ||||||||
MIRT150036 | MIDN | midnolin | 2 | 2 | ||||||||
MIRT246308 | HIST2H2AA3 | histone cluster 2 H2A family member a3 | 2 | 4 | ||||||||
MIRT246320 | HIST2H2AA4 | histone cluster 2 H2A family member a4 | 2 | 4 | ||||||||
MIRT248254 | SP1 | Sp1 transcription factor | 2 | 2 | ||||||||
MIRT257944 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT466973 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT492322 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT496204 | EFCAB1 | EF-hand calcium binding domain 1 | 2 | 2 | ||||||||
MIRT497568 | CCR6 | C-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT502990 | CCDC71L | coiled-coil domain containing 71 like | 2 | 8 | ||||||||
MIRT508300 | SIX5 | SIX homeobox 5 | 2 | 4 | ||||||||
MIRT522472 | ZAK | mitogen-activated protein kinase kinase kinase 20 | 2 | 2 | ||||||||
MIRT525825 | VIMP | selenoprotein S | 2 | 4 | ||||||||
MIRT528154 | BCL2L1 | BCL2 like 1 | 2 | 2 | ||||||||
MIRT532606 | SPTLC2 | serine palmitoyltransferase long chain base subunit 2 | 2 | 2 | ||||||||
MIRT551302 | RPRM | reprimo, TP53 dependent G2 arrest mediator homolog | 2 | 2 | ||||||||
MIRT568777 | FAM53C | family with sequence similarity 53 member C | 2 | 6 | ||||||||
MIRT570896 | METTL21A | methyltransferase like 21A | 2 | 2 | ||||||||
MIRT570963 | TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 2 | 2 | ||||||||
MIRT571167 | ZNF85 | zinc finger protein 85 | 2 | 2 | ||||||||
MIRT576751 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT609854 | DAZAP2 | DAZ associated protein 2 | 2 | 2 | ||||||||
MIRT627101 | PDRG1 | p53 and DNA damage regulated 1 | 2 | 2 | ||||||||
MIRT637060 | PRKAG1 | protein kinase AMP-activated non-catalytic subunit gamma 1 | 2 | 2 | ||||||||
MIRT639423 | PKP1 | plakophilin 1 | 2 | 2 | ||||||||
MIRT643208 | TYW3 | tRNA-yW synthesizing protein 3 homolog | 2 | 4 | ||||||||
MIRT646251 | PRSS38 | protease, serine 38 | 2 | 2 | ||||||||
MIRT647145 | CYP27C1 | cytochrome P450 family 27 subfamily C member 1 | 2 | 2 | ||||||||
MIRT647429 | ZKSCAN2 | zinc finger with KRAB and SCAN domains 2 | 2 | 2 | ||||||||
MIRT650666 | GAPDHP44 | glyceraldehyde 3 phosphate dehydrogenase pseudogene 44 | 2 | 2 | ||||||||
MIRT651816 | USP49 | ubiquitin specific peptidase 49 | 2 | 2 | ||||||||
MIRT657376 | HMGA1 | high mobility group AT-hook 1 | 2 | 2 | ||||||||
MIRT658105 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT658161 | FCHSD1 | FCH and double SH3 domains 1 | 2 | 2 | ||||||||
MIRT662754 | LRRC3C | leucine rich repeat containing 3C | 2 | 2 | ||||||||
MIRT667209 | NIPAL1 | NIPA like domain containing 1 | 2 | 2 | ||||||||
MIRT687003 | RPL35 | ribosomal protein L35 | 2 | 2 | ||||||||
MIRT707057 | NACC2 | NACC family member 2 | 2 | 2 | ||||||||
MIRT709048 | MRO | maestro | 2 | 2 | ||||||||
MIRT709054 | MGAT5B | mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B | 2 | 2 | ||||||||
MIRT709446 | VWA2 | von Willebrand factor A domain containing 2 | 2 | 2 | ||||||||
MIRT709847 | SNX12 | sorting nexin 12 | 2 | 2 | ||||||||
MIRT710790 | IFNLR1 | interferon lambda receptor 1 | 2 | 2 | ||||||||
MIRT711696 | GMPR | guanosine monophosphate reductase | 2 | 2 | ||||||||
MIRT712462 | KCNC3 | potassium voltage-gated channel subfamily C member 3 | 2 | 2 | ||||||||
MIRT713884 | MOB3A | MOB kinase activator 3A | 2 | 2 | ||||||||
MIRT715329 | NTN1 | netrin 1 | 2 | 2 | ||||||||
MIRT715927 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 2 | ||||||||
MIRT716533 | ATF5 | activating transcription factor 5 | 2 | 2 | ||||||||
MIRT716937 | CACNB1 | calcium voltage-gated channel auxiliary subunit beta 1 | 2 | 2 | ||||||||
MIRT717007 | MFSD6 | major facilitator superfamily domain containing 6 | 2 | 2 | ||||||||
MIRT719139 | DPYSL5 | dihydropyrimidinase like 5 | 2 | 2 | ||||||||
MIRT720853 | MEF2D | myocyte enhancer factor 2D | 2 | 2 | ||||||||
MIRT721484 | LTB4R2 | leukotriene B4 receptor 2 | 2 | 2 | ||||||||
MIRT721517 | DKK3 | dickkopf WNT signaling pathway inhibitor 3 | 2 | 2 | ||||||||
MIRT722895 | LRRC20 | leucine rich repeat containing 20 | 2 | 2 | ||||||||
MIRT723066 | GGA1 | golgi associated, gamma adaptin ear containing, ARF binding protein 1 | 2 | 2 | ||||||||
MIRT723086 | INSIG1 | insulin induced gene 1 | 2 | 2 | ||||||||
MIRT723353 | ASCL2 | achaete-scute family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT723483 | MINOS1 | mitochondrial inner membrane organizing system 1 | 2 | 2 | ||||||||
MIRT724576 | NOTCH2 | notch 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|